Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Antioxidants & Redox Signaling
|
February 9, 2010
Cytosolic disulfide bond formation in cells infected with large nucleocytoplasmic DNA viruses
Motti Hakim, Deborah Fass
Journal of Molecular Biology
|
July 7, 2009
Dimer interface migration in a viral sulfhydryl oxidase
Motti Hakim, Deborah Fass
Journal of Virology
|
July 15, 2011
Structure of a baculovirus sulfhydryl oxidase, a highly divergent member of the erv flavoenzyme family
Motti Hakim, Amitai Mandelbaum, Deborah Fass
Plos One
|
December 5, 2012
Exploring ORFan domains in giant viruses: structure of mimivirus sulfhydryl oxidase R596
Motti Hakim, Daria Ezerina, Assaf Alon, et al.
Oncotarget
|
September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Antioxidants & Redox Signaling
|
February 9, 2010
Cytosolic disulfide bond formation in cells infected with large nucleocytoplasmic DNA viruses
Motti Hakim, Deborah Fass
Journal of Molecular Biology
|
July 7, 2009
Dimer interface migration in a viral sulfhydryl oxidase
Motti Hakim, Deborah Fass
Journal of Virology
|
July 15, 2011
Structure of a baculovirus sulfhydryl oxidase, a highly divergent member of the erv flavoenzyme family
Motti Hakim, Amitai Mandelbaum, Deborah Fass
Plos One
|
December 5, 2012
Exploring ORFan domains in giant viruses: structure of mimivirus sulfhydryl oxidase R596
Motti Hakim, Daria Ezerina, Assaf Alon, et al.
Oncotarget
|
September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.
Page
of 1